| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.096 | 0.001 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |